Yesterday, a Director at Onconova Therapeutics (ONTX), Premkumar Reddy, sold shares of ONTX for $142.5K.
This is Reddy’s first Sell trade following 7 Buy transactions. In addition to Premkumar Reddy, one other ONTX executive reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Currently, Onconova Therapeutics has an average volume of 33.12M. ONTX’s market cap is $50.26 million and the company has a P/E ratio of 0.90. The company has a one-year high of $2.84 and a one-year low of $0.10.
Based on 4 analyst ratings, the analyst consensus is Hold with an average price target of $0.30, reflecting a -8.7% downside.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
